[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.139.136. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 22, 1995

Doxycycline Treatment and Desert Storm

Author Affiliations

The University of Texas M. D. Anderson Cancer Center Houston
Rhodon Foundation for Biomedical Research Kingwood, Tex

JAMA. 1995;273(8):618-619. doi:10.1001/jama.1995.03520320026026
Abstract

To the Editor.  —If the National Institutes of Health (NIH) Technology Assessment Workshop report on Operation Desert Storm syndrome/illnesses was meant to address fears that these illnesses are not being taken seriously and to establish practical working case definitions for the chronic illnesses associated with Operations Desert Shield and Desert Storm, it was not an auspicious start. After listening to the health complaints of numerous veterans of Operations Desert Shield and Desert Storm, including our stepdaughter and her colleagues who served in the US Army's 101st Airborne Division, and complaints about their inability to convince military hospitals and Veterans Affairs medical centers that they are suffering from a possible syndrome with the same major symptoms listed in the workshop report, we attempted to suggest that many of these symptoms can be explained by aggressive pathogenic mycoplasma infections, such as Mycoplasma incognitus or Mycoplasma penetrans,2 and they should be treatable

First Page Preview View Large
First page PDF preview
First page PDF preview
×